Cullinan Therapeutics Inc (CGEM)

SG&A Expenses

$50.33M

TTM · Period ending: · USD

CGEM logo

CGEM SG&A Expenses

Latest reported$50.33M
CGEM TTM SG&A Expenses ($5.48M → $50.33M)
High-resolution chart · PNG

CGEM sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Cullinan Therapeutics Inc SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
50,332,000
52,283,000
54,246,000
56,488,000
56,210,000
55,133,000
53,863,000
49,867,000
47,500,000
44,023,000
42,416,000
43,143,000
42,247,000
42,728,000
40,189,000
42,371,000
37,980,000
32,111,000
29,146,000
28,221,000
24,112,000
20,912,000
17,124,000
5,757,000
5,848,000
5,536,000
5,482,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.